12/02/2022 7:13 AM | Anavex Life Sciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/28/2022 4:03 PM | Anavex Life Sciences (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
06/29/2022 4:23 PM | Anavex Life Sciences (Issuer) Velden Claus Vander (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/29/2022 4:14 PM | Anavex Life Sciences (Issuer) Thomas Steffen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/29/2022 4:08 PM | Anavex Life Sciences (Issuer) Ma Jiong (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/29/2022 4:10 PM | Anavex Life Sciences (Issuer) Skarpelos Athanasios (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
06/29/2022 4:12 PM | Anavex Life Sciences (Issuer) Donhauser Peter D.O. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2022 4:08 PM | Anavex Life Sciences (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/27/2022 7:30 PM | Anavex Life Sciences (Issuer) Skarpelos Athanasios (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/27/2022 3:30 PM | Anavex Life Sciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/10/2022 3:31 PM | Anavex Life Sciences (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
09/13/2021 6:19 AM | Anavex Life Sciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/04/2021 4:30 PM | Anavex Life Sciences (Issuer) Donhauser Peter D.O. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/04/2021 4:36 PM | Anavex Life Sciences (Issuer) Boenisch Sandra (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/04/2021 4:38 PM | Anavex Life Sciences (Issuer) Velden Claus Vander (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/04/2021 4:40 PM | Anavex Life Sciences (Issuer) Ma Jiong (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/04/2021 4:26 PM | Anavex Life Sciences (Issuer) Thomas Steffen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/04/2021 4:19 PM | Anavex Life Sciences (Issuer) MISSLING CHRISTOPHER U (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/04/2021 4:22 PM | Anavex Life Sciences (Issuer) Skarpelos Athanasios (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/01/2021 8:48 PM | Anavex Life Sciences (Issuer) MISSLING CHRISTOPHER U (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/01/2021 8:45 PM | Anavex Life Sciences (Issuer) Boenisch Sandra (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2021 8:53 PM | Anavex Life Sciences (Issuer) Ma Jiong (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
05/28/2021 3:00 PM | Anavex Life Sciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/25/2021 8:30 PM | Anavex Life Sciences (Issuer) FAVUS ELLIOT (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/19/2021 7:47 AM | Anavex Life Sciences (Issuer) Donhauser Peter D.O. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/13/2021 3:29 PM | Anavex Life Sciences (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/09/2021 4:06 PM | Anavex Life Sciences (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/26/2021 8:31 PM | Anavex Life Sciences (Issuer) FAVUS ELLIOT (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2021 12:22 PM | Anavex Life Sciences (Issuer) Donhauser Peter D.O. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2021 1:22 PM | Anavex Life Sciences (Issuer) FAVUS ELLIOT (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2021 1:24 PM | Anavex Life Sciences (Issuer) Donhauser Peter D.O. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2021 1:26 PM | Anavex Life Sciences (Issuer) Boenisch Sandra (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2021 1:28 PM | Anavex Life Sciences (Issuer) Thomas Steffen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2021 1:29 PM | Anavex Life Sciences (Issuer) Skarpelos Athanasios (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2021 1:17 PM | Anavex Life Sciences (Issuer) MISSLING CHRISTOPHER U (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2021 1:20 PM | Anavex Life Sciences (Issuer) Velden Claus Vander (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/28/2020 4:27 PM | Anavex Life Sciences (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
12/28/2020 4:28 PM | Anavex Life Sciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/15/2020 6:06 AM | Anavex Life Sciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/06/2020 10:15 AM | Anavex Life Sciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
10/15/2020 6:02 AM | Anavex Life Sciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/06/2020 3:08 PM | Anavex Life Sciences (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/07/2020 3:32 PM | Anavex Life Sciences (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/01/2020 6:06 AM | Anavex Life Sciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/08/2020 3:30 PM | Anavex Life Sciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/08/2020 5:00 PM | Anavex Life Sciences (Issuer) Skarpelos Athanasios (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2020 5:00 PM | Anavex Life Sciences (Issuer) Donhauser Peter D.O. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2020 5:00 PM | Anavex Life Sciences (Issuer) FAVUS ELLIOT (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2020 5:00 PM | Anavex Life Sciences (Issuer) MISSLING CHRISTOPHER U (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2020 5:00 PM | Anavex Life Sciences (Issuer) Thomas Steffen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2020 5:00 PM | Anavex Life Sciences (Issuer) Velden Claus Vander (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2020 5:00 PM | Anavex Life Sciences (Issuer) Boenisch Sandra (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/16/2019 4:16 PM | Anavex Life Sciences (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
09/13/2019 4:10 PM | Anavex Life Sciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/03/2019 3:31 PM | Anavex Life Sciences (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
06/12/2019 3:58 PM | Anavex Life Sciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/06/2019 6:27 PM | Anavex Life Sciences (Issuer) Boenisch Sandra (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/07/2019 3:31 PM | Anavex Life Sciences (Issuer) MISSLING CHRISTOPHER U (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/08/2019 3:39 PM | Anavex Life Sciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/18/2019 5:26 AM | Anavex Life Sciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/07/2019 3:31 PM | Anavex Life Sciences (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
12/12/2018 3:39 PM | Anavex Life Sciences (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
10/09/2018 3:42 PM | Anavex Life Sciences (Issuer) Skarpelos Athanasios (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2018 4:29 PM | Anavex Life Sciences (Issuer) Boenisch Sandra (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2018 4:30 PM | Anavex Life Sciences (Issuer) Thomas Steffen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2018 4:31 PM | Anavex Life Sciences (Issuer) MISSLING CHRISTOPHER U (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2018 4:32 PM | Anavex Life Sciences (Issuer) Velden Claus Vander (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2018 4:33 PM | Anavex Life Sciences (Issuer) FAVUS ELLIOT (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2018 4:27 PM | Anavex Life Sciences (Issuer) Donhauser Peter D.O. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/06/2018 4:06 PM | Anavex Life Sciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/17/2018 4:23 PM | Anavex Life Sciences (Issuer) Boenisch Sandra (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2018 4:16 PM | Anavex Life Sciences (Issuer) MISSLING CHRISTOPHER U (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/24/2018 11:35 AM | Anavex Life Sciences (Issuer) Velden Claus Vander (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/20/2018 3:31 PM | Anavex Life Sciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/09/2018 2:16 PM | Anavex Life Sciences (Issuer) MISSLING CHRISTOPHER U (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2018 4:00 PM | Anavex Life Sciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/07/2018 10:01 AM | Anavex Life Sciences (Issuer) MISSLING CHRISTOPHER U (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2018 1:06 PM | Anavex Life Sciences (Issuer) MISSLING CHRISTOPHER U (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2018 7:56 AM | Anavex Life Sciences (Issuer) MISSLING CHRISTOPHER U (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/15/2017 3:09 PM | Anavex Life Sciences (Issuer) MISSLING CHRISTOPHER U (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/15/2017 3:11 PM | Anavex Life Sciences (Issuer) Boenisch Sandra (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2017 4:14 PM | Anavex Life Sciences (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |